Quantitative 1H NMR method for the routine spectroscopic determination of enantiomeric purity of active pharmaceutical ingredients fenfluramine, sertraline, and paroxetine

Magnetic Resonance in Chemistry

Volumn 43, Issue 11, 2005, Pages 910-917

  Salsbury, Jonathon S ^a   Isbester, Paul K ^a  

^a ALBANY MOLECULAR RESEARCH INC   (United States)

Author keywords

1H; Chiral solvation; Fenfluramine; NMR; Paroxetine; Quantitative NMR spectroscopy; Sertraline

Indexed keywords

CHROMATOGRAPHY; DRUG PRODUCTS; ENANTIOMERS; STEREOCHEMISTRY;

1H; ACTIVE PHARMACEUTICALS INGREDIENTS; CHIRAL SOLVATING AGENTS; CHIRAL SOLVATION; ENANTIOMERIC PURITY; FENFLURAMINE; PAROXETINE; QUANTITATIVE NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; QUANTITATIVE NUCLEAR MAGNETIC RESONANCES; SERTRALINE;

NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

FENFLURAMINE; PAROXETINE; PROTON; SERTRALINE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STANDARD; STEREOISOMERISM;

CHEMISTRY, PHARMACEUTICAL; FENFLURAMINE; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; PAROXETINE; PROTONS; REFERENCE STANDARDS; SERTRALINE; STEREOISOMERISM;

EID: 27244431786     PISSN: 07491581     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrc.1642     Document Type: Article

References (30)

1. Parker D. Chem. Rev. 1991; 91: 1441.
2. Food and Drug Administration (FDA). http://www.fda.gov/cder/guidance/ stereo.htm, publication date 5/1/1992.
3. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH): http://www.ich.org/ MediaServer.jser?@_ID=430 &@_MODE=GLB, publication date 10 1999.
4. Krstulovic AM. Chiral Separations by HPLC. Ellis Horwood: Chichester, 1988.
5. Yun J, Buchwald SL. J. Org. Chem. 2000; 65: 767.
6. Kaddoumi A, Nakashima MN, Nakashima K. J. Chromatogr., B 2001; 763: 79.
7. Pirkle WH, Hoover DJ. Top. Stereochem. 1982; 13: 263.
8. Raban M, Mislow K. Tetrahedron Lett. 1965; 6: 4249.
9. Pirkle WH. J. Am. Chem. Soc. 1966; 88: 1837.
10. Ejchart A, Jurczak J. Wiad. Chem. 1970; 24: 857.
11. Webb TH, Wilcox CS. Chem. Soc. Rev. 1993; 22: 383.
12. Prestat G, Marchand A, Lebreton J, Guingant A, Pradere JP. Tetrahedron: Asymmetry 1998; 9: 197.
13. Rosini C, Uccello-Barretta G, Pini D, Abete C, Salvadori P. J. Org. Chem. 1988; 53: 4579.
14. Benson SC, Cai P, Colon M, Haiza MA, Tokles M, Snyder JK. J. Org. Chem. 1988; 53: 5335.
15. Shapiro MJ, Archinal AE, Jarema MA. J. Org. Chem. 1989; 54: 5826.
16. Uccello-Barretta G, Balzano F, Menicagli R, Salvadori P. J. Org. Chem. 1996; 61: 363.
17. Enders D, Thomas CR, Runsink J. Tetrahedron: Asymmetry 1999; 10: 323.
18. Wenzel TJ, Thurston JE. J. Org. Chem. 2000; 65: 1243.
19. Parker D, Taylor RJ. Tetrahedron 1987; 43: 5451.
20. Pirkle WH, Sikkenga DL, Pavlin MS. J. Org. Chem. 1977; 42: 384.
21. Lingenfelter DS, Helgeson RC, Cram DJ. J. Org. Chem. 1981; 46: 393.
22. Braun S, Kalinowski H-O, Berger S. 150 and More Basic NMR Experiments. Wiley-VCH: Weinheim, 1998.
23. Kreidl J, Czibula L, Nemes A, Deutschne JI, Werkne PE, Nagyne BJ, Dobay L, Hegedues I, Harsanyi K, Borza I. PCT INT. Appl. WO9801424 a1 980115, 1998.
24. Dou L, Zeng JN, Gerochi D, Duda MP, Stuting HH. J. Chromatogr., A 1994; 679: 367.
25. Goument B, Duhamel L, Mauge R. Bull. Soc. Chim. Fr. 1993; 130: 450.
26. Ferretti R, Gallinella B, La Torre F, Lusi A. J. Chromatogr., A 1996; 731: 340.
27. Welch WM, Kraska AR, Sarges R, Koe BK. J. Med. Chem. 1984; 27: 1508.
28. Lautens M, Rovis T. J. Org. Chem. 1997; 62: 5246.
29. Lucangioli SE, Hermida LG, Tripodi VP, Rodriguez VG, Lopez EE, Rouge PD, Carducci CN. J. Chromatogr., A 2000; 871: 207.
30. Taylor MS, Jacobsen EN. J. Am. Chem. Soc. 2003; 125: 11 204.